Purpose: To examine factors associated with HMG-CoA reductase inhibitor (statin) management and the effect of therapeutic modifications on patients' abilities to reach their low-density lipoprotein-cholesterol (LDL-C) goal in a sample of managed care enrollees. Methods: This retrospective...